Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT

Clinical trial NCT07591649 · RECRUITING

Trial details

NCT number: NCT07591649
Sponsor: Masonic Cancer Center, University of Minnesota
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Adult AML Refractory AML Acute Myelogenous Leukemia

Start date: 2026-05-08
Primary completion: 2030-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.